Pacific Biosciences of California reports Q4 net loss decreases

Pacific Biosciences of California, Inc., a biotechnology company, has reported a net loss of $21.67 million, or $0.39 loss per share, for the fourth quarter ended December 31, 2012 compared to a net loss of $22.82 million, or $0.42 loss per share, for the fourth quarter ended December 31, 2011.

Total revenue for the fourth quarter ended December 31, 2012 was $5.88 million, compared to $12.44 million for the fourth quarter ended December 31, 2011.

Net loss for the year ended December 31, 2012 was $94.46 million, or $1.69 loss per share, compared to a net loss of $109.39 million, or $2.03 loss per share, for the year ended December 31, 2011.

Total revenue for the year ended December 31, 2012 was $25.98 million, compared to $33.86 million for the year ended December 31, 2011.